Your browser doesn't support javascript.
loading
Development of vaccines at the time of COVID-19.
Almond, Jeffrey; Hacker, Jörg; Harwood, Colin; Pizza, Mariagrazia; Rappuoli, Rino; Ron, Eliora Z; Sansonetti, Philippe; Vanderslott, Samantha; Wieler, Lothar H.
Afiliação
  • Almond J; The Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
  • Hacker J; German National Academy of Science Leopoldina, Jägerberg 1, 06108 Halle, Germany.
  • Harwood C; Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne NE2 4AX, UK.
  • Pizza M; GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy.
  • Rappuoli R; GSK Vaccines, Via Fiorentina, 1, 53100 Siena SI, Italy.
  • Ron EZ; The Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, PO Box 39040, Tel Aviv 6997801, Israel.
  • Sansonetti P; Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France.
  • Vanderslott S; Oxford Vaccine Group and Oxford Martin School, 34 Broad St, Oxford OX1 3BD, UK.
  • Wieler LH; Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany.
Microlife ; 1(1): uqaa003, 2020 Jul.
Article em En | MEDLINE | ID: mdl-34235437

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article